Kennedy and Oz say Medicaid isn't being cut. But state Medicaid directors say new policies are likely to cause many people to ...

In focusing on medical aid in dying solely as an end, we’ve missed out on the life that was lived,” writes physician Sai ...

Eli Lilly confirmed that it will allow more patients to apply for early access to retatrutide, an unapproved obesity drug ...

A study of New York’s court-ordered care for people with serious mental health conditions adds to the research on this type ...

It is no longer possible to ask the FDA to keep pace with software development by doing the same reviews faster,” writes Dana ...

Today, controversy over a regulator’s decision on AI scribes. Plus, a little more detail on Dexcom’s FDA pilot and an ...

Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77. Allison covers what hot startups are ...

Today, we’re getting ready for the FDA’s upcoming decision on Moderna’s mRNA flu shot, and see both a revived fight over 340B ...

The California Supreme Court sided with Gilead Sciences in a closely watched case over whether the company had a "duty" to ...

Six weeks after STAT reported that Eli Lilly granted a single 79-year-old patient special access to retatrutide, an ...

Medicare is removing flexibilities that have allowed "breakthrough" medical devices to leapfrog qualifications for extra ...

Two people have died in the cyclospora outbreak in Michigan in the first confirmed deaths in the U.S. related to the ...